Literature DB >> 8440609

Assessment of cognitive function in patients with systemic lupus erythematosus.

D Mulherin1, E Doherty, A O'Connell, B Bresnihan.   

Abstract

The spectrum of central nervous system manifestations of systemic lupus erythematosus (SLE) is very broad and has been found to include subtle subclinical cognitive dysfunction which may be detected only by the lengthy process of detailed neuropsychological evaluation. This study reports the value of estimating premorbid intelligence as a simple yet effective means of screening for subclinical cognitive dysfunction. Twenty one female patients with clinically quiescent SLE underwent neuropsychological examination at entry to the study. In all patients, this examination included measurement of full-scale intelligence quotient (IQ), verbal and performance IQ as well as verbal and visual memories. In addition, premorbid intelligence was estimated using the Schonell graded word reading test. Nine patients (43%) gave a history of neuropsychiatric (NP) disease. No difference was identified between the results of the neuropsychological evaluation in these 9 patients and in either the other SLE patients or in age and sex matched control patients. Sixteen patients were re-evaluated 1 year later. A comparison of measured full-scale IQ with the estimated premorbid intelligence identified a subgroup of 3 patients who demonstrated a significant reduction in intelligence. Unlike the other 13 patients, these 3 patients had multiple (3 or more) other features of cognitive impairment.

Entities:  

Mesh:

Year:  1993        PMID: 8440609     DOI: 10.1007/bf02942820

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  18 in total

1.  Clinical and subclinical involvement of the central nervous system in systemic lupus erythematosus.

Authors:  J A Denburg
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1990

Review 2.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

3.  Central nervous system lupus erythematosus. The need for classification.

Authors:  S S Kassan; M D Lockshin
Journal:  Arthritis Rheum       Date:  1979-12

Review 4.  CNS lupus.

Authors:  B Bresnihan
Journal:  Clin Rheum Dis       Date:  1982-04

5.  Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test.

Authors:  H E Nelson; A O'Connell
Journal:  Cortex       Date:  1978-06       Impact factor: 4.027

6.  Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus.

Authors:  S D Denburg; R M Carbotte; A A Long; J A Denburg
Journal:  Brain Behav Immun       Date:  1988-09       Impact factor: 7.217

7.  Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers.

Authors:  C L Bell; C Partington; M Robbins; F Graziano; P Turski; S Kornguth
Journal:  Arthritis Rheum       Date:  1991-04

8.  Systemic lupus erythematosus. A prospective analysis.

Authors:  R Grigor; J Edmonds; R Lewkonia; B Bresnihan; G R Hughes
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

9.  The use of current reading ability in the assessment of dementia.

Authors:  H E Nelson; P McKenna
Journal:  Br J Soc Clin Psychol       Date:  1975-09

10.  Prevalence of cognitive impairment in systemic lupus erythematosus.

Authors:  R M Carbotte; S D Denburg; J A Denburg
Journal:  J Nerv Ment Dis       Date:  1986-06       Impact factor: 2.254

View more
  1 in total

1.  Depression with psychotic features in a child with SLE: successful therapy with psychotropic medications--case report.

Authors:  Milica Pejovic Milovancevic; Vladimir Miletic; Smiljka Popovic Deusic; Saveta Draganic Gajic; Dusica Lecic Tosevski
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-10-10       Impact factor: 4.785

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.